BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17253773)

  • 1. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.
    Martinez Z; Zhu M; Han S; Fink AL
    Biochemistry; 2007 Feb; 46(7):1868-77. PubMed ID: 17253773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical alpha-synuclein forms highly conductive ion channels.
    Zakharov SD; Hulleman JD; Dutseva EA; Antonenko YN; Rochet JC; Cramer WA
    Biochemistry; 2007 Dec; 46(50):14369-79. PubMed ID: 18031063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
    Bharathi ; Rao KS
    Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
    Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R
    Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants of PLD2 inhibition by alpha-synuclein.
    Payton JE; Perrin RJ; Woods WS; George JM
    J Mol Biol; 2004 Apr; 337(4):1001-9. PubMed ID: 15033366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-bound structure and energetics of alpha-synuclein.
    Mihajlovic M; Lazaridis T
    Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside G(M1)-mediated amyloid-beta fibrillogenesis and membrane disruption.
    Chi EY; Frey SL; Lee KY
    Biochemistry; 2007 Feb; 46(7):1913-24. PubMed ID: 17256880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitration on the structure and aggregation of alpha-synuclein.
    Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
    Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
    Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
    J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid supported lipid bilayers containing monosialoganglioside GM1: a QCM-D and FRAP study.
    Weng KC; Kanter JL; Robinson WH; Frank CW
    Colloids Surf B Biointerfaces; 2006 Jun; 50(1):76-84. PubMed ID: 16730958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
    Antoine T; Priem B; Heyraud A; Greffe L; Gilbert M; Wakarchuk WW; Lam JS; Samain E
    Chembiochem; 2003 May; 4(5):406-12. PubMed ID: 12740812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes.
    Hegde ML; Rao KS
    Arch Biochem Biophys; 2007 Aug; 464(1):57-69. PubMed ID: 17537399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.